important regulator of HSPC cell fate and may be play a role in the pathogenesis of bone marrow failure.
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Introduction:
Multiple interactions between cytokines and growth factors with hematopoietic stem/progenitor cells (HSPCs) determine whether and how these cells remain viable to undergo self-renewal or commit to differentiation into specific lineages of mature blood cells in response to stress. 1-3 4,5 The interferon-inducible, dsRNA-activated protein kinase, PKR, is a sentinel stress kinase that initiates the response to diverse cellular challenges such as viral infection, hematopoietic growth factor deprivation, inflammatory cytokines, Toll-like receptor ligands, and chemo-radiation therapy. [6] [7] [8] We and others have reported that activated PKR can regulate proliferation and apoptosis by phosphorylation of eIF2α to inhibit new protein synthesis, activation of a PP2A-dependent Bcl2 dephosphorylation mechanism resulting in mitochondrial dysfunction and activation of signaling pathways such as NF-κB, p53 and STAT1. 6, [9] [10] [11] [12] Significantly, loss of PKR expression/activity has been associated with increased growth of human breast carcinoma, non-small cell lung cancer (NSCLC), B-cell CLL, and T-cell ALL, suggesting that loss of PKR activity may contribute to increased growth and malignancy. [13] [14] [15] [16] In contrast, increased PKR activity may inhibit cell growth and enhance stress responses leading to apoptosis. In support of this notion, activated PKR has been reported to be increased in myeloid progenitor To test the role of PKR in the regulation of HSPC self-renewal, differentiation and in response to stress, we constructed novel transgenic mice that express either human PKR (TgPKR) or a catalytically null/dominant-negative PKR mutant (TgDNPKR) specifically in hematopoietic cells to compare hematopoiesis in these mice with WT or PKR null mice. TgPKR mice demonstrate a much reduced frequency of HSPCs that display decreased proliferation, reduced hematopoietic colony formation and increased sensitivity to apoptosis-inducing cell stress. Interestingly, we have discovered that PKR knockout (PKRKO) mice have increased numbers of HSPCs. In addition, PKRKO cells have increased CFU activity and are more resistant to cell death. These data indicate that PKR is an unrecognized but necessary negative regulator of HSPC fate and may play a role in bone marrow failure states.
Materials and Methods:

Generation of human PKR and DNPKR transgenic mice:
The cDNAs encoding either the human PKR or the human dominant-negative PKR(K296R) mutant were amplified and ligated into pcr2.1 using PCR primers that inserted a 5' SfiI site and a 3' NotI site (Invitrogen). The PKR or DNPKR ORF was Founder mice were crossed with C57BL/6 mice to generate transgenic lines. Transgene negative siblings were used as wild type controls throughout the study. In addition, PKR knockout mice (PKRKO) were provided by Dr. Robert Silverman (Lerner Research Institute, Cleveland Clinic, Cleveland, OH). The study was approved by UF IACUC protocol #201102224.
Immunoblotting and Real-time PCR:
Snap-frozen mouse tissues were lysed and blotted with anti-human PKR (H00005610-M02, Abnova) or anti-mouse PKR (sc-6282, Santa Cruz). For protein Total RNAs were isolated from using RNeasy reagent (Qiagen), and cDNA prepared (Applied Biosystems). TaqMan assays were done for human PKR (assay Hs00169345_m1) and mouse PKR (assay Mm01235644_m1) with β-actin as an endogenous control. PCR was carried out in a 7500 Fast RT-PCR system at 95°C for 20 seconds, 59°C for 20 seconds, 72°C for 20 seconds, for 40 cycles (Applied Biosystems).
In vitro culture and survival assays of bone marrow progenitor cells:
BM was harvested from femurs/tibias by flushing the marrow with 5ml PBS containing 10% FBS using a 27-gauge needle syringe. Red cells were lysed by ACK lysis buffer (0.15M NH 4 Cl, 10mM KHCO 3, 0.1mM Na 2 EDTA, PH 7.4) and nucleated cells resuspended in PBS containing 10% FBS and counted.
To measure hematopoietic colony formation, 2x10 4 whole BM nucleated cells from wild-type, TgPKR, TgDNPKR, or PKRKO mice were plated in methylcellulose media (M3234; StemCell Technologies) containing 1x growth factor cocktail (3 U/ml EPO, 10 ng/ml mouse IL-3, 10 ng/ml mouse IL-6, and 50 ng/ml mouse SCF (R&D system). Colonies were enumerated following 7days using light microscopy. Co source delivered at 100 cGy/min).
Colony forming unit-spleen (CFU-S) assays:
Recipient mice 12 to 16 weeks of age were treated with10 Gy of γ-irradiation. chloroform, 10% acetic acid) and colonies counted.
Flow cytometry and quiescence/cell cycle analysis:
Bone marrow mononuclear cells were stained with a fluorochrome-conjugated lineage antibody cocktail (CD3, B220, Ter119, CD11b, and Gr-1) (BD Pharmingen), 
Complete blood count and pathology:
Peripheral blood samples were collected from cheek bleed and complete blood counts obtained using a Hemavet analyzer (Drew Scientific, Inc.).
Histopathologic examination was performed on H&E-stained specimens prepared from thymus, lymph nodes, spleen, kidney, lung, heart, liver fixed in alcoholicparaformaldahye solution and decalcified femur specimens were fixed in neutralbuffered 10% formalin. Bouin-fixed, paraffin-embedded tissues were sectioned and deparaffinized. Sections were counterstained with H&E. Bone marrow smears were prepared from femurs and stained with Wright-Geimsa.
Slides were viewed with an Olympus upright microscope equipped with U plan Fluorite objectives at 40x/0.75 and 100xoil/1.30 (Olympus, Tokyo, Japan) and Cytoseal mounting medium. Images were acquired using a DP71 digital camera with DP-BSW-V3.1 camera control software and processed with Adobe Photoshop version 7.0.
Statistical analysis:
All data are presented as the mean ± SEM. Statistical significance (P < 0.05) was determined by t test using Graphpad Prism v. 5.0. 
Results:
Hematopoietic-tissue specific expression of human PKR in mouse.
Transgenic mice were generated that express full-length human PKR (TgPKR) or a catalytically null, dominant-negative PKR(K296R) mutant (TgDNPKR) driven by the vav transcriptional elements to direct gene expression specifically in hematopoietic tissues ( Figure 1A) . 19, 20 Founder TgPKR or TgDNPKR mice were identified by PCR of genomic DNA ( Figure 1B ). Importantly, human PKR or DNPKR is highly expressed in Analysis of peripheral blood indicates that TgPKR mice have significantly lower total white blood cell, neutrophil, lymphocyte, platelet and hemoglobin counts compared to WT mice, indicating defective hematopoiesis (Table 1) . Furthermore, this trend becomes exaggerated as mice age for 16-18 months. In contrast, WBC, platelet and hemoglobin levels in PKRKO or TgDNPKR increase compared to WT mice and differences between the CBC of TgPKR and WT or TgDNPKR mice becomes more pronounced as mice age (Table 1) . Taken together, these findings indicate that aberrant activation of PKR in the hematopoietic compartment may play a role in bone marrow failure states. In addition, the absence of expression/activity of PKR during aging is clearly associated with increased numbers of hematopoietic cells.
PKR expression affects proliferation and differentiation of hematopoietic stem/progenitor cells.
To investigate whether aberrant expression/activation of PKR may affect proliferation and/or differentiation of HSPCs and to explain the changes observed in peripheral or BM, we carried out hematopoietic colony forming cell (CFC) assays using To assess the function of HSPCs we performed an in vivo colony-forming spleen (CFU-S) assay. Consistent with the findings of the in vitro CFC assay, TgPKR BM gave rise to significantly fewer while PKRKO BM gave rise to significantly more CFU-S compared to WT (Fig 3G and H Figure 5C ).
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To investigate the mechanism(s) involved in PKR-mediated inhibition of HSPC proliferation, western blotting was performed on Lin-cKit+ cell lysates. Significantly, HSPCs from TgPKR mice display elevated levels of several potent negative regulators of proliferation including phospho-eIF2α, IRF-1 and p21. In contrast, cells from TgDNPKR or PKRKO mice display decreased IRF-1 and increased phosphorylated Erk1/2 ( Figure 5D ). Furthermore, HSPCs from PKRKO mice have decreased CDK2
( Figure 5D ). These findings support previous reports that PKR is required for eIF2α and IRF-1 induced cell growth inhibition 6, 21, 22 PKR regulates stress survival of HSPCs in response to growth factor deprivation, inflammatory cytokines or irradiation.
To test whether PKR may play a role in regulating the response to stress in HSPCs, we measured cell survival following application of various stresses in clonogenic assays. First, we investigated whether PKR expression may affect the sensitivity to hematopoietic growth factor (HGF) deprivation. Following culture of HSPCs for increasing time in the absence of factors, cells were plated in methylcellulose containing SCF, IL-3, IL-6 and EPO and colonies scored after 7 days.
HSPCs isolated from TgPKR mice are significantly more sensitive to HGF deprivation with decreased survival exhibiting a half-life (i.e. time of deprivation at which 50% progenitor cell colonies survive) of 28 hours compared to 36 hours for WT cells (P < 0.01, Figure 6A ). Importantly, cells from the PKRKO mice were highly resistant to factor deprivation, exhibiting a half-life of 54 hours (P < 0.01; Figure 6A ). In addition, Annexin V analysis confirms that reduced survival results from increased apoptosis in TgPKR Figure 6B ). Interestingly, PKRKO cells display higher CFU efficiency in lower concentrations of HGFs (left shift of curve) compared to WT cells. In contrast, ,cells from TgPKR mice require more than four times the dose of HGFs to achieve the same 100% CFU efficiency as WT cells (i.e. right shift of curve; Figure 4C ).
As a control, we tested whether a pharmacological PKR inhibitor (PKRi) could rescue reduced CFU activity of TgPKR cells. Our results demonstrate that 300nM PKRi can significantly enhance colony formation of TgPKR cells in response to low concentrations of HGFs ( Figure 6D ). Although colony formation was moderately elevated by PKRi treatment of WT cells, little or no effect was observed in TgDNPKR or PKRKO BM (Figure 6E to G). These data strongly indicate that PKR activity is required for its inhibitory effect on hematopoiesis.
To examine the role of PKR during the response to inflammatory cytokines, BM cells were plated in methylcellulose medium containing HGFs with increasing concentrations of IFNγ or TNFα. 17 Both cytokines suppress CFU more potently in cells from TgPKR compared to WT mice ( Figures 6H and I) . Furthermore, the inhibitory effect of these cytokines is significantly reduced on TgDNPKR or PKRKO HSPCs, suggesting that activation of PKR is necessary for the myelosuppressive effect of inflammatory cytokines.
We next assessed the effect of PKR on radiosensitivity of BM cells in vitro. Cells were plated as above and immediately exposed to increasing doses of gamma irradiation. HSPCs from TgPKR mice were found to be significantly more sensitive to irradiation as evidenced by a lower D 37 (the radiation dose for a survival of 37%) of 1.48
For personal use only. on October 4, 2017. by guest www.bloodjournal.org From Gy (P < 0.05) and a reduced SF 2Gy (surviving fraction at 2Gy irradiation) of only 22.0% (P < 0.05) as compared with a D 37 of 2.05 Gy and SF 2Gy of 41.6% for WT cells ( Figure   6J ). Moreover, HSPCs from the PKRKO mice are highly resistant to radiation exposure with a D 37 of 2.68 Gy (P < 0.05) and an SF 2Gy of 60.7% (P < 0.05), respectively ( Figure   6J ). Thus, inhibition or loss of expression of PKR may prevent the myelosuppressive effect of irradiation.
Discussion
Loss of PKR expression/activity has been reported in hematological malignancies including B cell CLL and T cell ALL whereas activated PKR is reported to occur in close association with MDS in primary patient samples. 13, 15, 18 This suggests that PKR may play a role in regulating normal and malignant hematopoiesis. Therefore, we developed mice expressing either a human PKR or DNPKR transgene specifically in hematopoietic tissues and examined hematopoiesis in these mice and in PKR knockout mice. While a CMV-driven PKR transgenic mouse model has been reported, no effect was noted on hematopoiesis since the transgene was not expressed in hematopoietic tissues. 
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